Palabras clave
Riesgo
Enfermedad pulmonar
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar el desarrollo de síndromes respiratorios correlacionados con el tabaquismo pasivo. Métodos: Esta es una revisión integradora. Se utilizaron bases de datos del portal regional de la Biblioteca Regional en Salud. La búsqueda de artículos se realizó utilizando descriptores como “tabaquismo pasivo”, “riesgo” y “enfermedad pulmonar”. La revisión se realizó siguiendo los siguientes pasos: establecimiento del tema, definición de parámetros de elegibilidad, definición de criterios de inclusión y exclusión, verificación de publicaciones en bases de datos, análisis de la información encontrada, evaluación de los estudios encontrados y presentación de los resultados. Resultados: Se observó que los daños causados por el tabaquismo pasivo pueden generar una serie de consecuencias negativas para la salud en general, como riesgo para el desarrollo de enfermedades cardíacas, respiratorias y, principalmente, neoplasias malignas. Esta recopilación de factores demuestra la necesidad de combatir el tabaquismo y, en consecuencia, el tabaquismo pasivo. Consideraciones finales: Ante los hechos mencionados, fue posible inferir que la inhalación pasiva del humo del cigarrillo apunta a un mayor riesgo de agravar o desarrollar enfermedades respiratorias, como asma, EPOC y cáncer de pulmón.
Referencias
ABDEL-RAHMAN O. Incidence and Mortality of Lung Cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings from the PLCO Trial. Clinical Lung Cancer, 2020; 21: 415-420.
BASTIAN LA, et al. Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women’s Health Initiative. The Gerontologist, 2016; 56: S102–S111.
BLAAKMAN S, et al. Secondhand Smoke Exposure Reduction after NICU Discharge: Results of a Randomized Trial. Academic Pediatrics, 2015; 15(6): 605–612.
BOOALAYAN H, et al. Exposure to environmental tobacco smoke and prevalence of asthma among adolescents in a middle eastern country. BMC Public Health, 2020; 20: 1210.
BORRELLI B, et al. Motivating parents of kids with asthma to quit smoking: The effect of the teachable moment and increasing intervention intensity using a longitudinal randomized trial design. Addiction, 2016; 111(9): 1646–1655.
BUTLER KM, et al. Perceived Synergistic Risk for Lung Cancer After Environmental Report-Back Study on Home Exposure to Tobacco Smoke and Radon. American Journal of Health Promotion, 2019; 33(4): 597–600.
BUTZ AM, et al. Children with poorly controlled asthma: Randomized controlled trial of a home-based environmental control intervention. Pediatric Pulmonology, 2019; 54(3): 245–256.
BUTZ AM, et al. Factors Associated with Secondhand Smoke Exposure (SHS) in High-Risk Children with Asthma. J Asthma, 2020; 1–12.
COURAUD S, et al. BioCAST/IFCT-1002: Epidemiological and molecular features of lung cancer in never-smokers. European Respiratory Journal, 2015; 45(5): 1403–1414.
ELSHAZLY FA, et al. Effects of second-hand smoking on lung functions in athlete and non-athlete school-aged children – observational study. Afri Health Sci, 2020; 20(1): 368-75.
GRARUP PA, et al. Passive smoking is associated with poor asthma control during pregnancy: A prospective study of 500 pregnancies. PLoS ONE, 2014; 9(11).
GROEN E, et al. Evaluation of systematic assessment of asthma-like symptoms and tobacco smoke exposure in early childhood by well-child professionals: a randomised trial. PLoS One, 2014.
HANSEN MS, et al. The fraction of lung cancer attributable to smoking in the Norwegian Women and Cancer (NOWAC) Study. British Journal of Cancer, 2021; 124: 658–662.
HASSANZAD M, et al. Cotinine Level Is Associated with Asthma Severity in Passive Smoker Children. Iran J Allergy Asthma Immunol, 2015; 14(1): 67-73.
HUNTINGTON ML, et al. Radon, Secondhand Smoke, and Children in the Home: Creating a Teachable Moment for Lung Cancer Prevention. Public Health Nursing, 2016; 33(6): 529–538.
HUNTINGTON ML, et al. Use of theory-driven report back to promote lung cancer risk reduction. International Journal of Environmental Research and Public Health, 2021; 18(20).
HUTCHINSON SG, Motivational interviewing, and urine cotinine feedback to stop passive smoke exposure in children predisposed to asthma: a randomised controlled trial. Scientific reports, 2017; 7: 15473.
MOHAMMAD Y, et al. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group. International Journal of COPD, 2013; 8: 473-482.
PEREZ AV, et al. Characterization of severe asthma in the pediatric population. Allergol Immunopathol (Madr), 2021; 49(2): 60–65.
PIAZZA KM, et al.Inhaled medication usage in post-menopausal women and lifetime tobacco smoke exposure: The Women’s Health Initiative Observational Study. Maturitas, 2016; 90: 42–48.
UZELOTO JS, et al. Mucociliary Clearance of Different Respiratory Conditions: A Clinical Study. International Archives of Otorhinolaryngology, 2021; 25(1): e35–e40.
VIÑOLAS N, et al. Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07. Cancer investigation, 2017; 35: 1-8.
WAGENER TL, et al. Changes in risk perception following a smoking cessation intervention: the role of acculturation in a sample of Latino caregivers. Journal of Behavioral Medicine, 2014; 37(5): 1000–1008.
WANG A, et al. Active and passive smoking in relation to lung cancer incidence in the Women’s Health Initiative Observational Study prospective cohort. Annals of Oncology, 2015; 26(1): 221–230.
ZUBAIR T, et al. Role of passive smoking in non-smoking related chronic obstructive pulmonar disease. JPak Med Assoc, 2018; 68: 1310-1315.